Business Overview
Vynleads, Inc. is a wellness technology company focused on metabolic health and chronic, lifestyle-influenced conditions, with its flagship offering being Done With Diabetes, an app-based lifestyle-first wellness support program delivered through a digital platform with proprietary AI-enabled support. The company's strategic objective is to combine evidence-informed content, behavior change design, community accountability and AI-enabled support for delivery to consumers and enterprise partners such as employers, health plans, and pharmacy benefit managers. During the first quarter of 2026, the company generated no revenue while maintaining operating expenses and reported a net loss of $96,956.
Segment Performance
The company does not report segment performance. For the three months ended March 31, 2026, the company reported no revenue (compared to no revenue in the prior year quarter), cost of revenue of $2,028 (versus $4,718 in Q1 2025), gross loss of $2,028 (versus $4,718), operating expenses of $92,942 (versus $75,313), resulting in a net loss of $96,956 (versus $80,970 in Q1 2025). Net loss per share was $(0.01) compared to $(0.00) in the prior year period.
Key Risk Factors
The company faces substantial doubt about its ability to continue as a going concern, having experienced recurring operating losses since inception with negative working capital of $416,887 and an accumulated deficit of $3,137,552 as of March 31, 2026. The company has significant notes payable totaling $165,335, with some currently in default, and minimal cash of $262. The company's ability to continue operations depends critically on its ability to generate sufficient revenues, secure additional capital through private or public financing, and control expenses, with no assurances of achieving forecasted financial results or raising adequate capital.
